Picture of Bioxyne logo

BXN — Bioxyne Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Momentum

Relative Strength (%)
1m-4.3%
3m-25.61%
6m-46.34%
1yr-35.96%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-63.89%
50d MA-22.43%
200d MA-45.05%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-14.9%
Return on Equity0.31%
Operating Margin-13.23%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Bioxyne EPS forecast chart

Profile Summary

Bioxyne Limited is an Australia-based health and wellness products company. The Company is engaged in the development, manufacture and distribution of consumer dietary supplements and functional foods markets through its probiotic strain of Lactobacillus fermentum VRI-003 (PCC). The Company operates through two segments wholesale sales and direct sales. The Company research, develops, markets and distributes over the counter dietary supplement products and beauty products. It operates in the direct sales industry in Asia, New Zealand and Australia. It is also developing a range of functional food and beauty products containing ingredients sourced from New Zealand.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
September 23rd, 1998
Public Since
December 14th, 2000
No. of Employees
16
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
640,145,398

BXN Share Price Performance

Upcoming Events for BXN

Full Year 2022 Bioxyne Ltd Earnings Release

Bioxyne Ltd Annual Shareholders Meeting

Similar to BXN

Picture of Actinogen Medical logo

Actinogen Medical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adalta logo

Adalta

au flag iconAustralian Stock Exchange - SEATS

Picture of Alterity Therapeutics logo

Alterity Therapeutics

au flag iconAustralian Stock Exchange - SEATS

Picture of Amplia Therapeutics logo

Amplia Therapeutics

au flag iconAustralian Stock Exchange - SEATS

Picture of Anatara Lifesciences logo

Anatara Lifesciences

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email